S. Combe

1.3k total citations
25 papers, 760 citations indexed

About

S. Combe is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, S. Combe has authored 25 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in S. Combe's work include Venous Thromboembolism Diagnosis and Management (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). S. Combe is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). S. Combe collaborates with scholars based in France, United States and Sweden. S. Combe's co-authors include M Samama, Louis Desjardins, C Janbon, Carl‐Gustav Olsson, Alain Leizorovicz, Raza Alikhan, Amiram Eldor, Alexander T. Cohen, Alexander G.G. Turpie and Alexander T Cohen and has published in prestigious journals such as Blood, The American Journal of Cardiology and European Journal of Pharmacology.

In The Last Decade

S. Combe

23 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Combe France 9 656 482 206 151 146 25 760
Karlyn A. Martin United States 13 703 1.1× 672 1.4× 170 0.8× 65 0.4× 151 1.0× 39 1.0k
Sergio Siragusa Italy 14 614 0.9× 430 0.9× 291 1.4× 93 0.6× 271 1.9× 28 829
Robert G. Lerner United States 10 548 0.8× 464 1.0× 297 1.4× 86 0.6× 235 1.6× 22 818
Y Gruel France 10 796 1.2× 560 1.2× 361 1.8× 267 1.8× 183 1.3× 25 950
S. Siragusa Italy 12 522 0.8× 291 0.6× 260 1.3× 181 1.2× 199 1.4× 22 730
Nuala Peter Germany 8 715 1.1× 694 1.4× 153 0.7× 79 0.5× 141 1.0× 10 935
Terence G. Sparling Canada 5 517 0.8× 413 0.9× 261 1.3× 84 0.6× 148 1.0× 8 631
Kirill Lobastov Russia 12 360 0.5× 145 0.3× 213 1.0× 71 0.5× 49 0.3× 86 475
Usha Perepu United States 7 473 0.7× 345 0.7× 92 0.4× 158 1.0× 59 0.4× 17 579
Valerie Aston United States 10 353 0.5× 175 0.4× 134 0.7× 72 0.5× 97 0.7× 17 480

Countries citing papers authored by S. Combe

Since Specialization
Citations

This map shows the geographic impact of S. Combe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Combe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Combe more than expected).

Fields of papers citing papers by S. Combe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Combe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Combe. The network helps show where S. Combe may publish in the future.

Co-authorship network of co-authors of S. Combe

This figure shows the co-authorship network connecting the top 25 collaborators of S. Combe. A scholar is included among the top collaborators of S. Combe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Combe. S. Combe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blandinières, Adeline, et al.. (2024). Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report. Hämostaseologie.
2.
Sulpice, Eric, S. Combe, Gilberto S. Almeida, et al.. (2023). Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. Journal of Endocrinology. 256(3). 6 indexed citations
3.
Rugeri, Lucia, Annie Harroche, S. Combe, et al.. (2022). POSTER PRESENTATIONS. Haemophilia. 28(S1). 25–126. 5 indexed citations
4.
Duchemin, Jérôme, Élise Sourdeau, V. Roussel‐Robert, et al.. (2020). Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study. European Journal of Pharmacology. 891. 173764–173764. 2 indexed citations
5.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study. European Journal of Clinical Pharmacology. 73(1). 15–28. 3 indexed citations
6.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action. European Journal of Clinical Pharmacology. 72(9). 1041–1050. 4 indexed citations
7.
Samama, M, S. Combe, Jacqueline Conard, & Marie‐Hélène Horellou. (2011). Risk assessment models for thromboprophylaxis of medical patients. Thrombosis Research. 129(2). 127–132. 13 indexed citations
8.
Conard, J., et al.. (2011). Hétérogénéité pharmacologique des nouveaux anticoagulants. Journal des Maladies Vasculaires. 36. S10–S15. 4 indexed citations
9.
Alikhan, Raza, Alexander T. Cohen, S. Combe, et al.. (2004). Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness. Archives of Internal Medicine. 164(9). 963–963. 368 indexed citations
10.
Desjardins, Louis, L. Bara, Florent Boutitie, et al.. (2004). Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study. Archives of Pathology & Laboratory Medicine. 128(5). 519–526. 38 indexed citations
11.
Alikhan, Raza, Alexander T Cohen, S. Combe, et al.. (2003). Prevention of venous thromboembolism in medical patients with enoxaparin. Blood Coagulation & Fibrinolysis. 14(4). 341–346. 189 indexed citations
12.
Catella-Lawson, Francesca, Shiv Kapoor, Andrew J. Cucchiara, et al.. (2001). Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. The American Journal of Cardiology. 88(3). 236–242. 4 indexed citations
13.
Samama, Charles Marc, et al.. (1996). Are Low-Molecular-Weight Heparins Useful for the Prophylaxis and Treatment of Arterial Thrombi?. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 2). 57–64. 11 indexed citations
14.
Réach, I, et al.. (1994). [Optimization of enoxaparin dose in the prevention of coagulation in the circuits of hemodialysis: results of a multicenter study].. PubMed. 15(6). 395–401. 5 indexed citations
15.
Combe, S., et al.. (1993). A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery. European Journal of Vascular Surgery. 7(5). 554–560. 49 indexed citations
16.
Soria, J., et al.. (1992). Effect of heparin and enoxaparin on platelet interaction with fibrin clots. Thrombosis Research. 65(2). 187–191. 13 indexed citations
17.
Samama, Charles Marc, et al.. (1991). A Pilot Study on the Use of a Low Molecular Weight Heparin (Enoxaparin) in Arterial Reconstructive Surgery. Seminars in Thrombosis and Hemostasis. 17(4). 367–370. 11 indexed citations
18.
Samama, M, S. Combe, M.H. Horellou, et al.. (1991). Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery. Thrombosis Research. 61. 29–37. 10 indexed citations
19.
Samama, Meyer‐Michel & S. Combe. (1990). Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).. PubMed. 556. 91–5. 7 indexed citations
20.
Samama, Charles Marc, et al.. (1990). Utilisation per et postopératoire d'une héparine de bas poids moléculaire en chirurgie vasculaire périphérique. Annales Françaises d Anesthésie et de Réanimation. 9(2). 102–105. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karlyn A. Martin Breakdown of academic impact, for papers by Sergio Siragusa Breakdown of academic impact, for papers by Robert G. Lerner Breakdown of academic impact, for papers by Y Gruel Breakdown of academic impact, for papers by S. Siragusa Breakdown of academic impact, for papers by Nuala Peter Breakdown of academic impact, for papers by Terence G. Sparling Breakdown of academic impact, for papers by Kirill Lobastov Breakdown of academic impact, for papers by Usha Perepu Breakdown of academic impact, for papers by Valerie Aston
Rankless by CCL
2026